Pilot whole genome sequencing service: Bupa becomes first UK major private healthcare provider to pilot whole genome sequencing for selected UK customers, identifying risk of...
Treatment resistance caused by cancer cell plasticity constitutes a major challenge in the treatment of prostate cancer. Published in Nucleic Acids Research, a recent study...
New insight into combatting drug-resistant prostate cancer: New research from the University of Eastern Finland sheds light on the significance of the glucocorticoid receptor in...
Two renowned biomedical researchers have been awarded £1 million to undertake world-leading research into diseases such as prostate cancer and mitochondrial disease at Northumbria University....
Prostate cancer’s resistance to treatment can be reversed in some patients by stopping hijacked white blood cells from being ‘pulled into’ tumours, according to new...
Patients with localised prostate cancer have a good chance of survival, but mortality rates among those with advanced, metastatic forms of the condition remain high....
NHS Prostate Cancer Treatments Surge in England: The number of men having treatment for prostate cancer has jumped by more than a quarter in England...
Cause of metastasis in prostate cancer discovered: Prostate cancers remain localised in the majority of cases, giving affected individuals a good chance of survival. However,...
Prostate cancer: "liquid biopsies" allow non-invasive diagnosis of metastatic cancers: In future, newly identified biomarkers could be used alongside imaging techniques for the non-invasive diagnosis...
Researchers at the University of East Anglia have shown that a prostate cancer urine test can identify men at 'intermediate risk' who can safely avoid...